Dietrich A. Stephan's Insider Trades & SAST Disclosures

Dietrich A. Stephan's most recent trade in NeuBase Therapeutics Inc was a trade of 655,000 Common Stock done . Disclosure was reported to the exchange on Feb. 13, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
NeuBase Therapeutics Inc
Dietrich A. Stephan Director, President and CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Feb 2023 655,000 1,471,775 (8%) 3% 0 Common Stock
NeuBase Therapeutics Inc
Dietrich A. Stephan Director, President and CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Feb 2023 655,000 1,864,680 - - Stock option (right to buy)
NeuBase Therapeutics Inc
Dietrich A. Stephan Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2022 306,000 306,000 - - Employee Stock option (right to buy)
NeuBase Therapeutics Inc
Dietrich A. Stephan Director, President and CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 5.00 per share. 26 Apr 2021 12,000 24,525 (0%) 0% 5 60,000 Common Stock
NeuBase Therapeutics Inc
Dietrich A. Stephan Director, President and CEO, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 29 Dec 2020 2,547,639 2,547,639 (14%) 14% 0 Common Stock
NeuBase Therapeutics Inc
Dietrich A. Stephan Director, President and CEO, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 29 Dec 2020 1,273,820 1,273,819 (7%) 7% 0 Common Stock
NeuBase Therapeutics Inc
Dietrich A. Stephan Director, President and CEO, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 29 Dec 2020 1,273,819 2,547,639 (14%) 7% 0 Common Stock
NeuBase Therapeutics Inc
Dietrich A. Stephan Director, President and CEO, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 29 Dec 2020 1,273,819 2,547,639 (14%) 7% 0 Common Stock
NeuBase Therapeutics Inc
Dietrich A. Stephan Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Dec 2020 164,925 164,925 - - Stock option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades